Nav: Home

Heart enlargement is a common cause of sudden death in young people

June 03, 2004

A seminar in this week's issue of THE LANCET highlights the frequency, diagnosis and management of hypertrophic cardiomyopathy, an unexplained thickening of the heart in young adults that has a 1% annual risk of sudden death.

Dr. Perry Elliott from University College, London, UK and Professor William McKenna from The Heart Hospital, London state that this genetically transmitted disease affects 1 in 500 adults and is the commonest cause of sudden death in otherwise fit young people and athletes.

The condition results from an abnormal heart muscle protein, and usually becomes detectable by the completion of the pubertal growth spurt. Symptoms are variable, ranging from none to chest pain or breathlessness on exertion. A family history of sudden death in a young adult may be present. Signs of hypertrophic cardiomyopathy can be seen on electrocardiogram, but formal diagnosis requires more specialised imaging.

Treatment is aimed at relieving symptoms and preventing abnormal heart rhythms. This can be accomplished by medication, surgery or an implantable defibrillator, which automatically delivers an electric shock when an abnormal heart rhythm develops.

Professor McKenna comments: "The past two decades have seen the identification of disease causing genes and the ability to identify at risk patients and prevent sudden death. With better understanding of the disease process, targeted treatments to treat symptoms and prevent disease development are being sought."
-end-
Contact: Professor William J. McKenna, The Heart Hospital, 16-18 Westmoreland Street, London W1G 8PH, UK; T): 0-207-573-8841; E): william.mckenna@uclh.org.

Lancet

Related Hypertrophic Cardiomyopathy Articles:

US pediatric heart transplant waitlist policy change falls short of intended benefits
In March 2016, the Organ Procurement and Transplantation Network revised its criteria for prioritizing children awaiting heart transplantation in the US with the intention of reducing the number of deaths on the waitlist, but a new study suggests unintended consequences.
Possible treatment breakthrough for the rare disease arrhythmogenic right ventricular cardiomyopathy
Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Puerta de Hierro hospital in Majadahonda have found a possible treatment for this disease.
Being overweight as a teen may be associated with cardiomyopathy in adulthood
The risk of developing cardiomyopathy, which often leads to heart failure, increased in adult Swedish men who were even mildly overweight around age 18.
Being overweight as a teen may be associated with higher risk of heart muscle disease in adulthood
The risk of developing cardiomyopathy, which often leads to heart failure, increased in adult Swedish men who were even mildly overweight around age 18.
A new role for genetics in cancer therapy-induced cardiomyopathy
A team of investigators from Brigham and Women's Hospital and Harvard Medical School finds that genetics may be at play and elucidates rare genetic variants which may influence risk for developing cancer therapy-induced cardiomyopathy.
Multiple mechanisms behind disease associated with unexpected heart attacks
An examination of three mutations associated with hypertrophic cardiomyopathy -- a disease best known for revealing itself as an unexpected, fatal heart attack during strenuous exercise -- found separate mechanisms at work at the molecular level.
Heart disease in pregnancy: A special look at peripartum cardiomyopathy
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P.
Scientists unravel genetic basis of hypertrophic cardiomyopathy in Finns
One third of hypertrophic cardiomyopathy cases in Finland are caused by one of the four major mutations, a new study from the University of Eastern Finland and Kuopio University Hospital shows.
Penn team uses gene editing to personalize clinical care for family with cardiomyopathy
More and more, through sequencing done for medical reasons or done by direct-to-consumer companies, people learn they have variants of disease genes with uncertain significance to their health.
Some heart patients ride roller coasters and other thrill-seeking activities despite warnings
Adults with an inherited thickening of the heart muscle, often don't stop participating in thrill-seeking activities despite recommendations that they should.
More Hypertrophic Cardiomyopathy News and Hypertrophic Cardiomyopathy Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.